Topical cannabidiol (medicinal cannabis) for rheumatoid arthritis trial
Researchers from Western Sydney University and the University of Sydney are looking for people with rheumatoid arthritis to take part in a clinical trial on topical cannabidiol (CBD or a type of medicinal cannabis). Early studies suggest medicinal cannabis may have beneficial effects on pain and function in arthritis, however more research is needed. Topical […]
Oz Medicann Group Strengthens Australia’s Role in Global Biotechnology Through a Strategic Partnership with NeoCannBio
Oz Medicann Group (OMG), a leading Australian biotech company, has announced a strategic partnership with NeoCannBio (NCB), a biotech company based in South Korea, to accelerate the commercialisation of clinically validated cannabinoid-based therapeutics across Asia. OMG is leading the way in research, development and commercialisation of innovative treatment therapies for a range of high clinical […]
